The Relation of 25-Hydroxyvitamin D Level with Metabolic Syndrome in Type 2 Diabetes Mellitus Patients

M.I. Diah Pramudianti, Dian Ariningrum, Medityas Winda Krissinta

Abstract


Type 2 Diabetes Mellitus (DM) is a metabolic disorder characterized by hyperglycemia. Metabolic Syndrome (MS) is a
complex metabolic disorder like hyperglycemia, obesity, dyslipidemia, and hypertension. Vitamin D controls genes
associated with the regulation of insulin and renin production. The aim of this study was to analyze the relation between
total levels of 25-hydroxyvitamin D [25(OH)D] and the incidence of MS in type 2 DM patients. This was an observational
study with a cross-sectional design conducted from October to November 2018 in Dr. Moewardi Hospital Surakarta on 84
people with type 2 DM. All subjects were 34-75 years old. The research data were analyzed with a 2x2 test table to determine
the Prevalence Ratio (PR) of each study variable, then multivariate analysis with logistic regression was continued. The mean
total level of 25(OH)D was 18.01±6.10 ng/dL. Bivariate and continued with multivariate PR analysis showed poor glycemic
control with the incidence of MS (PR: 11.154; 95% Cl: 3.933-31.631; p=0.001); female sex (PR : 1.788; 95% Cl: 0.750-4.261;
p=0.188); age < 50 year (PR: 1.644; 95% Cl: 0.614-4.404; p=0.321); and total 25(OH)D deficiency (PR: 1.250; 95%
Cl: 0.317-2.022; p=0.637). Total 25(OH)D level was not associated with the incidence of MS in the type 2 DM patients. Further
study was needed using healthy group control to explain the role of vitamin D in type 2 DM.


Keywords


Type 2 DM, metabolic syndrome, 25(OH)D

Full Text:

PDF

References


PERKENI. Konsensus pengelolaan dan pencegahan

diabetes melitus tipe 2 di Indonesia 2015. In; 2015:

Pengurus Besar Perkumpulan Endokrinologi

Indonesia (PB PERKENI). 2015; 1-14.

International Diabetes Federation. IDF diabetes atlas.

sixth Ed., 2013 [cited August 15, 2018]. Available at:

www.idf.org/diabetesatlas.

Milici N. A Short history of the metabolic syndrome

definitions. Proc. Rom. Acad. 2010; 13-20.

International Diabetes Federation. The IDF consensus

worldwide definition of the metabolic syndrome.2006

[cited at Juni 15, 2018]. Available at: https://www.idf.

org/component/attachments/attachments.HTML?id

=705&task=download.

Bikle DD. Vitamin D metabolism, mechanism of action,

and clinical application. Chemistry & Biology, 2014;

: 319-329.

Cândido FG, Bressan J. Vitamin D: Link between

osteoporosis, obesity, and diabetes?. Int. J. Mol. Sci,

; 15: 6569-6591.

Strange RC, Shipman KE, Ramachandran S. Metabolic

syndrome: A review of the role of vitamin D in

mediating susceptibility and outcome. World J

Diabetes, 2015; 6(7): 896-911.

Bland R, Markovic D, Hills CE, Hughes SV, Chan SL,

e t a l . E x p r e s s i o n o f 2 5 - h y d r o x y v i t a m i n

D3-1 - alpha-hydroxylase in pancreatic islets. Journal

of Steroid Biochemistry & Molecular Biology, 2004;

–90: 121-125.

Eftekhari MH, Sohrab Z, Parsa N, Nezhad MJZ. Role of

gender in the prevalence of metabolic syndrome and population. Int Cardiovasc Res J, 2015; 9(4): 231-237.

Valve R, Sivenius R, Miettinen R, Pihlajamaki J,

Rissanen A, et al. Two polymorphisms in the

peroxisome proliferator-activated receptor-g gene

are associated with severe overweight among obese

women. The Journal of Clinical Endocrinology &

Metabolism, 1999; 84(10): 3708-3712.

Williams CM. Lipid metabolism in women.

Proceedings of the Nutrition Society. 2004; 63:

–160.

Prasad K, Dash AK, Das BC. Prevalence and risk factors

for metabolic syndrome in Asian Indians: A

community study from urban Eastern India. J

Cardiovasc Dis Res, 2012; 3(3): 204-211.

Ogbera AO. Prevalence and gender distribution of the

metabolic syndrome. Diabetology and Metabolic

Syndrome, 2010; 2(1): 1-5.

Kraja AT, Borecki IB, North K, Tang W, Myers RH,

Hopkins PN, et al. Longitudinal and age trends of

metabolic syndrome and its risk factors: The family

heart study. Nutrition & Metabolism, 2006; 3(41): 1-9.

Al LİR, Sönmezer MÇ, Çiçek AG, Keskin M, Efe FK,

Çimen İM. Evaluation of the relationship between

vitamin D levels and metabolic syndrome

components. Biomed Res, 2017; 28(20): 8821-8826.

Gradillas-Garcíaa A, Álvarez J, Rubiob JA, de Abajo FJ.

Relationship between vitamin D deficiency and

metabolic syndrome in adult population of the

Community of Madrid. Endocrinol Nutr, 2015; 62(4):

-187.

Fondjo LA, Owiredu WKBA, Sakyi SA, Laing EF,

Adotey-Kwofie MA, et al. Vitamin D status and its

association with insulin resistance among type 2

diabetics: A case-control study in Ghana. 2017 [cited

a t S e p t e m b e r 1 0 , 2 0 1 8 ] A v a i l a b l e a t :

https://doi.org/10.1371/journal.pone.0175388.

Tenenbaum A, Fisman EZ, Motro M. Metabolic

syndrome and type 2 diabetes mellitus: Focus on

peroxisome proliferator-activated receptors (PPAR).

Cardiovascular Diabetology, 2003; 2: 1-7.

Athanassiou IK, Athanassiou P, Gkountouvas A,

Kaldrymides P. Vitamin D and glycemic control in

diabetes mellitus type 2. Ther Adv Endocrinol Metab,

; 4(4): 122-128.

Worawongprapa O. Glycemic control in diabetes with

metabolic syndrome in community hospital. J Med

Assoc Thai, 2008; 91(5): 641-647.




DOI: http://dx.doi.org/10.24293/ijcpml.v26i2.1469

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.